Low-temperature synthesis of thymoquinone and harmaline compounds
Low-temperature syntheses of thymoquinone/harmaline compounds which are useful for the treatment of human diabetes and cancers, and the derivatives, solvates, prodrugs, isomers, and tautomers of such compounds.
1. A composition comprising one or more of the following compounds, and the isomers, tautomers, solvates, esters, metal complexes, and salts thereof:
2. The composition of claim 1 , said compound having a molecular weight of about 360 or about 378.
3. A method of treating a human suffering from cancer and/or diabetes, said method comprising administering a therapeutically-effective amount of a composition according to claim 1 to a human in need thereof.
4. The method of claim 3 , said human being a diabetic patient.
5. The method of claim 3 , said human being a cancer patient.
6. The method of claim 5 , wherein said cancer patient is suffering from lymphoma.
7. A process for preparing a composition according to claim 1 , said method comprising reacting harmaline and thymoquinone in a non-interfering solvent and carrying out the reaction between said thymoquinone and harmaline at a temperature of less than about 10° C. for at least 4 hours.
8. The process of claim 7 , said reacting step comprises mixing together thymoquinone and harmaline in a noninterfering solvent to yield a reaction mixture and allowing said reaction mixture to stand at a temperature of less than about 10° C. for a time period of at least 4 hours.
9. The process of claim 8 , wherein said reaction is carried out a temperature of less than about 0° C. for a time period from about 6 hours to about 100 hours.
10. The process of claim 8 , wherein said thymoquinone and harmaline are mixed together in a weight ratio of from about 1:0.1 to about 1:2.
11. The process of claim 8 , wherein said reaction is carried out a temperature of from about −18° C. to about −100° C. for a time period from about 6 hours to about 100 hours.